ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Colloidal InSb Quantum Dots for eSWIR Photodetection via Decoupling Nucleation and Growth.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Colloidal InSb quantum dots (QDs) offer a critical heavy-metal-free platform for extended short-wave infrared (eSWIR) optoelectronics. However, achieving the large QD sizes necessary to access the key eSWIR region beyond 1700 nm has remained a longstanding challenge, owing to the strongly coupled nucleation and growth inherent to the conventional one-pot co-reduction synthetic route. Here, a two-step hot-injection method is developed to address this limitation: low-temperature co-reduction generates intermediate nanoparticles, followed by injection into hot solvent to trigger crystallization and growth. This approach decouples coreduction-reaction-driven nucleation from diffusion-controlled growth, enabling independent control over each stage. Optical and structural evolution reveals a nonclassical pathway: amorphous-crystalline intermediates crystallize and grow via Ostwald ripening, with kinetics governed by the strength of solvent coordination. Using non-coordinating nonadecene accelerates ripening, yielding monodisperse InSb QDs tunable from ∼5 to ∼12 nm with absorption covering 1600-2500 nm. Solid-state ligand exchange with InCl
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.